Valneva

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Our vision is to contribute to a world in which no one dies or suffers from a vaccine-preventable disease. Valneva USA, Inc. is focused on the marketing and distribution of Valneva’s Japanese encephalitis vaccine, IXIARO®, in the US.

The company has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.